Ibaraki, Japan

Hiroshi Nagase

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 31(Granted Patents)


Location History:

  • Ibaraki, JP (2015 - 2023)
  • Tsukuba, JP (2017 - 2023)

Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Hiroshi Nagase: Innovator in Pharmaceutical Chemistry

Introduction

Hiroshi Nagase is a prominent inventor based in Ibaraki, Japan, known for his significant contributions to pharmaceutical chemistry. With a total of 13 patents to his name, he has made remarkable advancements in the treatment of various medical conditions.

Latest Patents

Among his latest patents, one focuses on the use of morphinan derivatives for the treatment of opioid delta receptor agonist-related diseases. This method involves administering an effective amount of a pharmaceutical composition containing a morphinan derivative that exhibits opioid δ receptor agonist activity. Another notable patent is for a sulfonamide derivative or pharmaceutically acceptable acid-addition salt, which aims to provide a novel low-molecular-weight compound showing orexin receptor agonist activity. This compound is expected to be useful as a prophylactic or therapeutic agent for narcolepsy and similar conditions.

Career Highlights

Hiroshi Nagase has worked with notable organizations such as Nippon Chemiphar Co., Ltd. and the University of Tsukuba. His work in these institutions has allowed him to explore innovative solutions in the field of pharmaceuticals.

Collaborations

Some of his coworkers include Eriko Nakata and Hideaki Fujii, who have collaborated with him on various projects, contributing to the advancement of their shared research goals.

Conclusion

Hiroshi Nagase's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for new therapeutic options in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…